Day One BiopharmaceuticalsDAWN

那斯達克 · USD
10.78
-0.55
(-4.85%)
盤中 01/14 02:17 (UTC+8)
01/14 02:17 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • 0.08
  • 0.94
  • 0.29
  • 0.31
  • 0.34
  • 0.40
icon
  • -
  • -
  • -
  • -
  • -
  • 1044.54
  • -68.85
  • 5.32
  • 10.23
  • 17.36
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
39,795
33,908
30,761
29,208
93,761
8,192
-
-
-
-
營業成本
4,4803,7652,8842,9821,590707----
營業毛利
35,315
30,143
27,877
26,226
92,171
7,485
-
-
-
-
營業費用
59,56665,117------51,43849,254
研發費用
31,41936,14939,61961,82333,56392,10640,21037,34833,16332,182
推銷及管理費用
28,14728,96829,32529,73528,97230,18626,55722,16918,27517,072
非經常性項目費用
----------
其他營業費用
----------
營業利益
-24,251
-34,974
-41,067
-65,332
29,636
-114,807
-66,767
-59,517
-51,438
-49,254
其他收入及費用
4,5254,6525,0716,0926,519111,9524,3555,0065,2883,391
利息費用
----------
稅前純益
-19,726
-30,322
-35,996
-59,240
36,155
-2,855
-62,412
-54,511
-46,150
-45,863
所得稅
---6,474-8821,552----
稅後純益
-19,726
-30,322
-35,996
-65,714
37,037
-4,407
-62,412
-54,511
-46,150
-45,863
基本每股稅後盈餘(元)
-0.19-0.29-0.35-0.630.38-0.05-0.72--0.54-0.61
稀釋每股稅後盈餘(元)
-0.19-0.29-0.35-0.690.44-0.05-0.72-0.64-0.53-0.61
基本平均股數(千股)
103381.00103069.00102710.00102513.0096623.0087121.0086679.00-85952.0074964.00
稀釋平均股數(千股)
103381.00103069.00102710.00102199.0096937.0087121.0086679.00-85952.0074964.00
還原基本每股稅後盈餘(元)
-0.19-0.29-0.35-0.630.38-0.05-0.72--0.54-0.61
還原稀釋每股稅後盈餘(元)
-0.19-0.29-0.35-0.690.44-0.05-0.72-0.64-0.53-0.61
還原基本平均股數(千股)
103,381103,069102,710102,51396,62387,12186,679-85,95274,964
還原稀釋平均股數(千股)
103,381103,069102,710102,19996,93787,12186,679-85,95274,964
EBITDA(千元)
-22,913-33,510-39,352-61,30435,524-3,344-63,588-55,984-48,695-51,030

大家都在看

HOT